A phase II study of anlotinib in the first-line treatment of locally advanced or metastatic soft tissue sarcoma.

被引：0
|
作者：
Huang, Xin
Ye, Zhaoming
Li, Tao
Wei, Yongzhong
Wang, Shoufeng
Liu, Yunxia
Chen, Jia
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou, Peoples R China
[2] Univ Chinese Acad Sci, Canc Hosp, Hangzhou, Peoples R China
[3] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China
[4] Nanjing Univ, Sch Med, Drum Tower Hosp, Nanjing, Peoples R China
[5] Hangzhou Third Hosp, Hangzhou, Peoples R China
[6] Nanjing Med Univ, Canc Hosp, Nanjing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e23531
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23531
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Chemotherapy for metastatic and locally advanced soft tissue sarcoma
    Le Cesne, A.
    Cioffi, A.
    ONCOLOGIE, 2007, 9 (02) : 114 - 125
  • [32] First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma A Phase 2b Randomized Clinical Trial
    Chawla, Sant P.
    Papai, Zsuzsanna
    Mukhametshina, Guzel
    Sankhala, Kamalesh
    Vasylyev, Leonid
    Fedenko, Alexander
    Khamly, Kenneth
    Ganjoo, Kristen
    Nagarkar, Rajnish
    Wieland, Scott
    Levitt, Daniel J.
    JAMA ONCOLOGY, 2015, 1 (09) : 1272 - 1280
  • [33] A retrospective study of anlotinib combined with adriamycin and ifosfamide in unresectable soft tissue sarcoma.
    Long, Zuoyao
    Lu, Yajie
    Li, Minghui
    Chen, Guojing
    Li, Jing
    Fu, Zhanli
    Akbar, Yunus
    Zhang, Hong-Mei
    Wang, Zhen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] Phase 1/2 study of safety/efficacy using trabectedin, ipilimumab and nivolumab triple therapy as first line treatment of advanced soft tissue sarcoma.
    Gordon, Erlinda Maria
    Chua-Alcala, Victoria S.
    Kim, Katherine
    Andrali, Shiva Sreenath
    Del Rosario, Marie
    Tseng, William W.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] Pazopanib for the treatment of metastatic nonadipocytic soft-tissue sarcoma.
    Aydin, Fazil
    Topcu, Turkan Ozturk
    Ozdemir, Feyyaz
    Sahin, Nazim Onur
    Kavgaci, Halil
    Kandaz, Mustafa
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] A pilot study of first-line olaratumab, doxorubicin and ifosfamide in patients with metastatic soft tissue sarcoma
    Olga Vornicova
    Nissim Haim
    Gil Bar-Sela
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 919 - 923
  • [37] A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group
    P A Cassier
    A Lefranc
    E Y Amela
    C Chevreau
    B N Bui
    A Lecesne
    I Ray-Coquard
    S Chabaud
    N Penel
    Y Berge
    J Dômont
    A Italiano
    F Duffaud
    A-C Cadore
    V Polivka
    J-Y Blay
    British Journal of Cancer, 2013, 109 : 909 - 914
  • [38] A pilot study of first-line olaratumab, doxorubicin and ifosfamide in patients with metastatic soft tissue sarcoma
    Vornicova, Olga
    Haim, Nissim
    Bar-Sela, Gil
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (04) : 919 - 923
  • [39] A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group
    Cassier, P. A.
    Lefranc, A.
    Amela, E. Y.
    Chevreau, C.
    Bui, B. N.
    Lecesne, A.
    Ray-Coquard, I.
    Chabaud, S.
    Penel, N.
    Berge, Y.
    Domont, J.
    Italiano, A.
    Duffaud, F.
    Cadore, A-C
    Polivka, V.
    Blay, J-Y
    BRITISH JOURNAL OF CANCER, 2013, 109 (04) : 909 - 914
  • [40] Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group phase II study
    Saeter, G
    Alvegard, TA
    Monge, OR
    Strander, H
    Turesson, I
    Klepp, R
    Soderberg, M
    Wist, E
    Raabe, N
    Erlanson, M
    Solheim, OP
    Hannisdal, E
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (10) : 1551 - 1558
12345